Global Enteric Disease Testing and Therapeutic Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Enteric Disease Testing and Therapeutic market size was valued at US$ 2948.8 million in 2023. With growing demand in downstream market, the Enteric Disease Testing and Therapeutic is forecast to a readjusted size of US$ 3266 million by 2030 with a CAGR of 1.5% during review period.
The research report highlights the growth potential of the global Enteric Disease Testing and Therapeutic market. Enteric Disease Testing and Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Enteric Disease Testing and Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Enteric Disease Testing and Therapeutic market.
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Enteric Disease Testing and Therapeutic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Enteric Disease Testing and Therapeutic market. It may include historical data, market segmentation by Type (e.g., Bacterial Disease, Viral Disease), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Enteric Disease Testing and Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Enteric Disease Testing and Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Enteric Disease Testing and Therapeutic industry. This include advancements in Enteric Disease Testing and Therapeutic technology, Enteric Disease Testing and Therapeutic new entrants, Enteric Disease Testing and Therapeutic new investment, and other innovations that are shaping the future of Enteric Disease Testing and Therapeutic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Enteric Disease Testing and Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Enteric Disease Testing and Therapeutic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Enteric Disease Testing and Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Enteric Disease Testing and Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Enteric Disease Testing and Therapeutic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Enteric Disease Testing and Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Enteric Disease Testing and Therapeutic market.
Market Segmentation:
Enteric Disease Testing and Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Enteric Disease Testing and Therapeutic market size was valued at US$ 2948.8 million in 2023. With growing demand in downstream market, the Enteric Disease Testing and Therapeutic is forecast to a readjusted size of US$ 3266 million by 2030 with a CAGR of 1.5% during review period.
The research report highlights the growth potential of the global Enteric Disease Testing and Therapeutic market. Enteric Disease Testing and Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Enteric Disease Testing and Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Enteric Disease Testing and Therapeutic market.
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Enteric Disease Testing and Therapeutic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Enteric Disease Testing and Therapeutic market. It may include historical data, market segmentation by Type (e.g., Bacterial Disease, Viral Disease), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Enteric Disease Testing and Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Enteric Disease Testing and Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Enteric Disease Testing and Therapeutic industry. This include advancements in Enteric Disease Testing and Therapeutic technology, Enteric Disease Testing and Therapeutic new entrants, Enteric Disease Testing and Therapeutic new investment, and other innovations that are shaping the future of Enteric Disease Testing and Therapeutic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Enteric Disease Testing and Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Enteric Disease Testing and Therapeutic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Enteric Disease Testing and Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Enteric Disease Testing and Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Enteric Disease Testing and Therapeutic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Enteric Disease Testing and Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Enteric Disease Testing and Therapeutic market.
Market Segmentation:
Enteric Disease Testing and Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Bacterial Disease
- Viral Disease
- Parasitic Disease
- Hospital
- Specialty Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- GlaxoSmithKline
- Becton Dickinson
- bioMйrieux
- Sanofi
- Bayer Pharma
- Bio-Rad
- Quest Diagnostics
- Trinity Biotech
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enteric Disease Testing and Therapeutic Market Size 2019-2030
2.1.2 Enteric Disease Testing and Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Enteric Disease Testing and Therapeutic Segment by Type
2.2.1 Bacterial Disease
2.2.2 Viral Disease
2.2.3 Parasitic Disease
2.3 Enteric Disease Testing and Therapeutic Market Size by Type
2.3.1 Enteric Disease Testing and Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
2.4 Enteric Disease Testing and Therapeutic Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Others
2.5 Enteric Disease Testing and Therapeutic Market Size by Application
2.5.1 Enteric Disease Testing and Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
3 ENTERIC DISEASE TESTING AND THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Enteric Disease Testing and Therapeutic Market Size Market Share by Players
3.1.1 Global Enteric Disease Testing and Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Enteric Disease Testing and Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENTERIC DISEASE TESTING AND THERAPEUTIC BY REGIONS
4.1 Enteric Disease Testing and Therapeutic Market Size by Regions (2019-2024)
4.2 Americas Enteric Disease Testing and Therapeutic Market Size Growth (2019-2024)
4.3 APAC Enteric Disease Testing and Therapeutic Market Size Growth (2019-2024)
4.4 Europe Enteric Disease Testing and Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
5.2 Americas Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024)
5.3 Americas Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024)
6.2 APAC Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024)
6.3 APAC Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Enteric Disease Testing and Therapeutic by Country (2019-2024)
7.2 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024)
7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enteric Disease Testing and Therapeutic by Region (2019-2024)
8.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENTERIC DISEASE TESTING AND THERAPEUTIC MARKET FORECAST
10.1 Global Enteric Disease Testing and Therapeutic Forecast by Regions (2025-2030)
10.1.1 Global Enteric Disease Testing and Therapeutic Forecast by Regions (2025-2030)
10.1.2 Americas Enteric Disease Testing and Therapeutic Forecast
10.1.3 APAC Enteric Disease Testing and Therapeutic Forecast
10.1.4 Europe Enteric Disease Testing and Therapeutic Forecast
10.1.5 Middle East & Africa Enteric Disease Testing and Therapeutic Forecast
10.2 Americas Enteric Disease Testing and Therapeutic Forecast by Country (2025-2030)
10.2.1 United States Enteric Disease Testing and Therapeutic Market Forecast
10.2.2 Canada Enteric Disease Testing and Therapeutic Market Forecast
10.2.3 Mexico Enteric Disease Testing and Therapeutic Market Forecast
10.2.4 Brazil Enteric Disease Testing and Therapeutic Market Forecast
10.3 APAC Enteric Disease Testing and Therapeutic Forecast by Region (2025-2030)
10.3.1 China Enteric Disease Testing and Therapeutic Market Forecast
10.3.2 Japan Enteric Disease Testing and Therapeutic Market Forecast
10.3.3 Korea Enteric Disease Testing and Therapeutic Market Forecast
10.3.4 Southeast Asia Enteric Disease Testing and Therapeutic Market Forecast
10.3.5 India Enteric Disease Testing and Therapeutic Market Forecast
10.3.6 Australia Enteric Disease Testing and Therapeutic Market Forecast
10.4 Europe Enteric Disease Testing and Therapeutic Forecast by Country (2025-2030)
10.4.1 Germany Enteric Disease Testing and Therapeutic Market Forecast
10.4.2 France Enteric Disease Testing and Therapeutic Market Forecast
10.4.3 UK Enteric Disease Testing and Therapeutic Market Forecast
10.4.4 Italy Enteric Disease Testing and Therapeutic Market Forecast
10.4.5 Russia Enteric Disease Testing and Therapeutic Market Forecast
10.5 Middle East & Africa Enteric Disease Testing and Therapeutic Forecast by Region (2025-2030)
10.5.1 Egypt Enteric Disease Testing and Therapeutic Market Forecast
10.5.2 South Africa Enteric Disease Testing and Therapeutic Market Forecast
10.5.3 Israel Enteric Disease Testing and Therapeutic Market Forecast
10.5.4 Turkey Enteric Disease Testing and Therapeutic Market Forecast
10.5.5 GCC Countries Enteric Disease Testing and Therapeutic Market Forecast
10.6 Global Enteric Disease Testing and Therapeutic Forecast by Type (2025-2030)
10.7 Global Enteric Disease Testing and Therapeutic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Enteric Disease Testing and Therapeutic Product Offered
11.1.3 Abbott Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Enteric Disease Testing and Therapeutic Product Offered
11.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Information
11.3.2 Becton Dickinson Enteric Disease Testing and Therapeutic Product Offered
11.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Becton Dickinson Main Business Overview
11.3.5 Becton Dickinson Latest Developments
11.4 bioMйrieux
11.4.1 bioMйrieux Company Information
11.4.2 bioMйrieux Enteric Disease Testing and Therapeutic Product Offered
11.4.3 bioMйrieux Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 bioMйrieux Main Business Overview
11.4.5 bioMйrieux Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Enteric Disease Testing and Therapeutic Product Offered
11.5.3 Sanofi Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Bayer Pharma
11.6.1 Bayer Pharma Company Information
11.6.2 Bayer Pharma Enteric Disease Testing and Therapeutic Product Offered
11.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bayer Pharma Main Business Overview
11.6.5 Bayer Pharma Latest Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Information
11.7.2 Bio-Rad Enteric Disease Testing and Therapeutic Product Offered
11.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio-Rad Main Business Overview
11.7.5 Bio-Rad Latest Developments
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Information
11.8.2 Quest Diagnostics Enteric Disease Testing and Therapeutic Product Offered
11.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Quest Diagnostics Main Business Overview
11.8.5 Quest Diagnostics Latest Developments
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Information
11.9.2 Trinity Biotech Enteric Disease Testing and Therapeutic Product Offered
11.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Trinity Biotech Main Business Overview
11.9.5 Trinity Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enteric Disease Testing and Therapeutic Market Size 2019-2030
2.1.2 Enteric Disease Testing and Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Enteric Disease Testing and Therapeutic Segment by Type
2.2.1 Bacterial Disease
2.2.2 Viral Disease
2.2.3 Parasitic Disease
2.3 Enteric Disease Testing and Therapeutic Market Size by Type
2.3.1 Enteric Disease Testing and Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
2.4 Enteric Disease Testing and Therapeutic Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Others
2.5 Enteric Disease Testing and Therapeutic Market Size by Application
2.5.1 Enteric Disease Testing and Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
3 ENTERIC DISEASE TESTING AND THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Enteric Disease Testing and Therapeutic Market Size Market Share by Players
3.1.1 Global Enteric Disease Testing and Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Enteric Disease Testing and Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENTERIC DISEASE TESTING AND THERAPEUTIC BY REGIONS
4.1 Enteric Disease Testing and Therapeutic Market Size by Regions (2019-2024)
4.2 Americas Enteric Disease Testing and Therapeutic Market Size Growth (2019-2024)
4.3 APAC Enteric Disease Testing and Therapeutic Market Size Growth (2019-2024)
4.4 Europe Enteric Disease Testing and Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
5.2 Americas Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024)
5.3 Americas Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024)
6.2 APAC Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024)
6.3 APAC Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Enteric Disease Testing and Therapeutic by Country (2019-2024)
7.2 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024)
7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enteric Disease Testing and Therapeutic by Region (2019-2024)
8.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENTERIC DISEASE TESTING AND THERAPEUTIC MARKET FORECAST
10.1 Global Enteric Disease Testing and Therapeutic Forecast by Regions (2025-2030)
10.1.1 Global Enteric Disease Testing and Therapeutic Forecast by Regions (2025-2030)
10.1.2 Americas Enteric Disease Testing and Therapeutic Forecast
10.1.3 APAC Enteric Disease Testing and Therapeutic Forecast
10.1.4 Europe Enteric Disease Testing and Therapeutic Forecast
10.1.5 Middle East & Africa Enteric Disease Testing and Therapeutic Forecast
10.2 Americas Enteric Disease Testing and Therapeutic Forecast by Country (2025-2030)
10.2.1 United States Enteric Disease Testing and Therapeutic Market Forecast
10.2.2 Canada Enteric Disease Testing and Therapeutic Market Forecast
10.2.3 Mexico Enteric Disease Testing and Therapeutic Market Forecast
10.2.4 Brazil Enteric Disease Testing and Therapeutic Market Forecast
10.3 APAC Enteric Disease Testing and Therapeutic Forecast by Region (2025-2030)
10.3.1 China Enteric Disease Testing and Therapeutic Market Forecast
10.3.2 Japan Enteric Disease Testing and Therapeutic Market Forecast
10.3.3 Korea Enteric Disease Testing and Therapeutic Market Forecast
10.3.4 Southeast Asia Enteric Disease Testing and Therapeutic Market Forecast
10.3.5 India Enteric Disease Testing and Therapeutic Market Forecast
10.3.6 Australia Enteric Disease Testing and Therapeutic Market Forecast
10.4 Europe Enteric Disease Testing and Therapeutic Forecast by Country (2025-2030)
10.4.1 Germany Enteric Disease Testing and Therapeutic Market Forecast
10.4.2 France Enteric Disease Testing and Therapeutic Market Forecast
10.4.3 UK Enteric Disease Testing and Therapeutic Market Forecast
10.4.4 Italy Enteric Disease Testing and Therapeutic Market Forecast
10.4.5 Russia Enteric Disease Testing and Therapeutic Market Forecast
10.5 Middle East & Africa Enteric Disease Testing and Therapeutic Forecast by Region (2025-2030)
10.5.1 Egypt Enteric Disease Testing and Therapeutic Market Forecast
10.5.2 South Africa Enteric Disease Testing and Therapeutic Market Forecast
10.5.3 Israel Enteric Disease Testing and Therapeutic Market Forecast
10.5.4 Turkey Enteric Disease Testing and Therapeutic Market Forecast
10.5.5 GCC Countries Enteric Disease Testing and Therapeutic Market Forecast
10.6 Global Enteric Disease Testing and Therapeutic Forecast by Type (2025-2030)
10.7 Global Enteric Disease Testing and Therapeutic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Enteric Disease Testing and Therapeutic Product Offered
11.1.3 Abbott Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Enteric Disease Testing and Therapeutic Product Offered
11.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Information
11.3.2 Becton Dickinson Enteric Disease Testing and Therapeutic Product Offered
11.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Becton Dickinson Main Business Overview
11.3.5 Becton Dickinson Latest Developments
11.4 bioMйrieux
11.4.1 bioMйrieux Company Information
11.4.2 bioMйrieux Enteric Disease Testing and Therapeutic Product Offered
11.4.3 bioMйrieux Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 bioMйrieux Main Business Overview
11.4.5 bioMйrieux Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Enteric Disease Testing and Therapeutic Product Offered
11.5.3 Sanofi Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Bayer Pharma
11.6.1 Bayer Pharma Company Information
11.6.2 Bayer Pharma Enteric Disease Testing and Therapeutic Product Offered
11.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bayer Pharma Main Business Overview
11.6.5 Bayer Pharma Latest Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Information
11.7.2 Bio-Rad Enteric Disease Testing and Therapeutic Product Offered
11.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio-Rad Main Business Overview
11.7.5 Bio-Rad Latest Developments
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Information
11.8.2 Quest Diagnostics Enteric Disease Testing and Therapeutic Product Offered
11.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Quest Diagnostics Main Business Overview
11.8.5 Quest Diagnostics Latest Developments
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Information
11.9.2 Trinity Biotech Enteric Disease Testing and Therapeutic Product Offered
11.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Trinity Biotech Main Business Overview
11.9.5 Trinity Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Enteric Disease Testing and Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Bacterial Disease
Table 3. Major Players of Viral Disease
Table 4. Major Players of Parasitic Disease
Table 5. Enteric Disease Testing and Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 8. Enteric Disease Testing and Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 11. Global Enteric Disease Testing and Therapeutic Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Player (2019-2024)
Table 13. Enteric Disease Testing and Therapeutic Key Players Head office and Products Offered
Table 14. Enteric Disease Testing and Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Enteric Disease Testing and Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Regions (2019-2024)
Table 19. Global Enteric Disease Testing and Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Enteric Disease Testing and Therapeutic Market Size Market Share by Country (2019-2024)
Table 23. Americas Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 25. Americas Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 27. APAC Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Region (2019-2024)
Table 29. APAC Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 31. APAC Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 33. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Country (2019-2024)
Table 35. Europe Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 37. Europe Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Enteric Disease Testing and Therapeutic
Table 46. Key Market Challenges & Risks of Enteric Disease Testing and Therapeutic
Table 47. Key Industry Trends of Enteric Disease Testing and Therapeutic
Table 48. Global Enteric Disease Testing and Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Enteric Disease Testing and Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Enteric Disease Testing and Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Enteric Disease Testing and Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Abbott Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 53. Abbott Enteric Disease Testing and Therapeutic Product Offered
Table 54. Abbott Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Abbott Main Business
Table 56. Abbott Latest Developments
Table 57. GlaxoSmithKline Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 58. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product Offered
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. GlaxoSmithKline Latest Developments
Table 62. Becton Dickinson Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 63. Becton Dickinson Enteric Disease Testing and Therapeutic Product Offered
Table 64. Becton Dickinson Main Business
Table 65. Becton Dickinson Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Becton Dickinson Latest Developments
Table 67. bioMйrieux Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 68. bioMйrieux Enteric Disease Testing and Therapeutic Product Offered
Table 69. bioMйrieux Main Business
Table 70. bioMйrieux Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. bioMйrieux Latest Developments
Table 72. Sanofi Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 73. Sanofi Enteric Disease Testing and Therapeutic Product Offered
Table 74. Sanofi Main Business
Table 75. Sanofi Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Sanofi Latest Developments
Table 77. Bayer Pharma Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 78. Bayer Pharma Enteric Disease Testing and Therapeutic Product Offered
Table 79. Bayer Pharma Main Business
Table 80. Bayer Pharma Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Bayer Pharma Latest Developments
Table 82. Bio-Rad Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 83. Bio-Rad Enteric Disease Testing and Therapeutic Product Offered
Table 84. Bio-Rad Main Business
Table 85. Bio-Rad Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Bio-Rad Latest Developments
Table 87. Quest Diagnostics Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 88. Quest Diagnostics Enteric Disease Testing and Therapeutic Product Offered
Table 89. Quest Diagnostics Main Business
Table 90. Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Quest Diagnostics Latest Developments
Table 92. Trinity Biotech Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 93. Trinity Biotech Enteric Disease Testing and Therapeutic Product Offered
Table 94. Trinity Biotech Main Business
Table 95. Trinity Biotech Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Trinity Biotech Latest Developments
Table 1. Enteric Disease Testing and Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Bacterial Disease
Table 3. Major Players of Viral Disease
Table 4. Major Players of Parasitic Disease
Table 5. Enteric Disease Testing and Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 8. Enteric Disease Testing and Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 11. Global Enteric Disease Testing and Therapeutic Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Player (2019-2024)
Table 13. Enteric Disease Testing and Therapeutic Key Players Head office and Products Offered
Table 14. Enteric Disease Testing and Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Enteric Disease Testing and Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Regions (2019-2024)
Table 19. Global Enteric Disease Testing and Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Enteric Disease Testing and Therapeutic Market Size Market Share by Country (2019-2024)
Table 23. Americas Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 25. Americas Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 27. APAC Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Region (2019-2024)
Table 29. APAC Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 31. APAC Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 33. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Country (2019-2024)
Table 35. Europe Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 37. Europe Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Enteric Disease Testing and Therapeutic
Table 46. Key Market Challenges & Risks of Enteric Disease Testing and Therapeutic
Table 47. Key Industry Trends of Enteric Disease Testing and Therapeutic
Table 48. Global Enteric Disease Testing and Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Enteric Disease Testing and Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Enteric Disease Testing and Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Enteric Disease Testing and Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Abbott Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 53. Abbott Enteric Disease Testing and Therapeutic Product Offered
Table 54. Abbott Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Abbott Main Business
Table 56. Abbott Latest Developments
Table 57. GlaxoSmithKline Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 58. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product Offered
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. GlaxoSmithKline Latest Developments
Table 62. Becton Dickinson Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 63. Becton Dickinson Enteric Disease Testing and Therapeutic Product Offered
Table 64. Becton Dickinson Main Business
Table 65. Becton Dickinson Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Becton Dickinson Latest Developments
Table 67. bioMйrieux Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 68. bioMйrieux Enteric Disease Testing and Therapeutic Product Offered
Table 69. bioMйrieux Main Business
Table 70. bioMйrieux Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. bioMйrieux Latest Developments
Table 72. Sanofi Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 73. Sanofi Enteric Disease Testing and Therapeutic Product Offered
Table 74. Sanofi Main Business
Table 75. Sanofi Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Sanofi Latest Developments
Table 77. Bayer Pharma Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 78. Bayer Pharma Enteric Disease Testing and Therapeutic Product Offered
Table 79. Bayer Pharma Main Business
Table 80. Bayer Pharma Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Bayer Pharma Latest Developments
Table 82. Bio-Rad Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 83. Bio-Rad Enteric Disease Testing and Therapeutic Product Offered
Table 84. Bio-Rad Main Business
Table 85. Bio-Rad Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Bio-Rad Latest Developments
Table 87. Quest Diagnostics Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 88. Quest Diagnostics Enteric Disease Testing and Therapeutic Product Offered
Table 89. Quest Diagnostics Main Business
Table 90. Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Quest Diagnostics Latest Developments
Table 92. Trinity Biotech Details, Company Type, Enteric Disease Testing and Therapeutic Area Served and Its Competitors
Table 93. Trinity Biotech Enteric Disease Testing and Therapeutic Product Offered
Table 94. Trinity Biotech Main Business
Table 95. Trinity Biotech Enteric Disease Testing and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Trinity Biotech Latest Developments
LIST OF FIGURES
Figure 1. Enteric Disease Testing and Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Enteric Disease Testing and Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Enteric Disease Testing and Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Enteric Disease Testing and Therapeutic Sales Market Share by Country/Region (2023)
Figure 8. Enteric Disease Testing and Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Type in 2023
Figure 10. Enteric Disease Testing and Therapeutic in Hospital
Figure 11. Global Enteric Disease Testing and Therapeutic Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Enteric Disease Testing and Therapeutic in Specialty Clinic
Figure 13. Global Enteric Disease Testing and Therapeutic Market: Specialty Clinic (2019-2024) & ($ Millions)
Figure 14. Enteric Disease Testing and Therapeutic in Others
Figure 15. Global Enteric Disease Testing and Therapeutic Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Application in 2023
Figure 17. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Player in 2023
Figure 18. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Enteric Disease Testing and Therapeutic Market Size 2019-2024 ($ Millions)
Figure 20. APAC Enteric Disease Testing and Therapeutic Market Size 2019-2024 ($ Millions)
Figure 21. Europe Enteric Disease Testing and Therapeutic Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size 2019-2024 ($ Millions)
Figure 23. Americas Enteric Disease Testing and Therapeutic Value Market Share by Country in 2023
Figure 24. United States Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Region in 2023
Figure 29. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Type in 2023
Figure 30. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Application in 2023
Figure 31. China Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Country in 2023
Figure 38. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Figure 39. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Figure 40. Germany Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 54. APAC Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 55. Europe Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 57. United States Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 58. Canada Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 61. China Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 62. Japan Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 63. Korea Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 65. India Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 66. Australia Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 67. Germany Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 68. France Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 69. UK Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 70. Italy Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 71. Russia Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 72. Spain Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 75. Israel Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 78. Global Enteric Disease Testing and Therapeutic Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Enteric Disease Testing and Therapeutic Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Enteric Disease Testing and Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Enteric Disease Testing and Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Enteric Disease Testing and Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Enteric Disease Testing and Therapeutic Sales Market Share by Country/Region (2023)
Figure 8. Enteric Disease Testing and Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Type in 2023
Figure 10. Enteric Disease Testing and Therapeutic in Hospital
Figure 11. Global Enteric Disease Testing and Therapeutic Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Enteric Disease Testing and Therapeutic in Specialty Clinic
Figure 13. Global Enteric Disease Testing and Therapeutic Market: Specialty Clinic (2019-2024) & ($ Millions)
Figure 14. Enteric Disease Testing and Therapeutic in Others
Figure 15. Global Enteric Disease Testing and Therapeutic Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Application in 2023
Figure 17. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Player in 2023
Figure 18. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Enteric Disease Testing and Therapeutic Market Size 2019-2024 ($ Millions)
Figure 20. APAC Enteric Disease Testing and Therapeutic Market Size 2019-2024 ($ Millions)
Figure 21. Europe Enteric Disease Testing and Therapeutic Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size 2019-2024 ($ Millions)
Figure 23. Americas Enteric Disease Testing and Therapeutic Value Market Share by Country in 2023
Figure 24. United States Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Region in 2023
Figure 29. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Type in 2023
Figure 30. APAC Enteric Disease Testing and Therapeutic Market Size Market Share by Application in 2023
Figure 31. China Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Country in 2023
Figure 38. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Figure 39. Europe Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Figure 40. Germany Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Enteric Disease Testing and Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 54. APAC Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 55. Europe Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 57. United States Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 58. Canada Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 61. China Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 62. Japan Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 63. Korea Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 65. India Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 66. Australia Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 67. Germany Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 68. France Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 69. UK Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 70. Italy Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 71. Russia Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 72. Spain Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 75. Israel Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Enteric Disease Testing and Therapeutic Market Size 2025-2030 ($ Millions)
Figure 78. Global Enteric Disease Testing and Therapeutic Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Enteric Disease Testing and Therapeutic Market Size Market Share Forecast by Application (2025-2030)
